Robert Elston

发表

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.

T. Asselah, M. Imamura, M. Yuen, 2022, The New England journal of medicine.

Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial

M. Yuen, J. Jang, Jung-Hwan Yoon, 2021, Nature Medicine.

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Tom Chu, Peter W Angus, P. Angus, 2010, The Lancet.

Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease

Eugene I. Drigalenko, R. Elston, S. Poduslo, 1998, Neurology.

2nd International Conference on Progressive Multifocal Leukoencephalopathy (PML) 2015: JCV virology, progressive multifocal leukoencephalopathy pathogenesis, diagnosis and risk stratification, and new approaches to prevention and treatment

Ilse S. Peterson, K. Tyler, E. Major, 2015, Journal of NeuroVirology.

Comparison of Pharmacokinetics of the GalNAc-Conjugated Antisense Oligonucleotide GSK3389404 in Participants with Chronic Hepatitis B Infection across the Asia-Pacific Region

D. Theodore, Kelong Han, M. Paff, 2022, Antimicrobial agents and chemotherapy.

Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy.

M. Imamura, K. Chayama, Y. Karino, 2022, Journal of hepatology.

Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection not on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study

S. Lim, H. Janssen, E. Janczewska, 2022, Journal of Hepatology.

Reply to: Bepirovirsen / GSK3389404: antisense or TLR9 agonists?

M. Yuen, Shihyun You, Robert Elston, 2022, Journal of hepatology.

Efficacy and Safety of Bepirovirsen in Hepatitis B. Reply.

M. Yuen, D. Theodore, Robert Elston, 2023, The New England journal of medicine.

B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection.

D. Theodore, Stuart Kendrick, M. Paff, 2023, Advances in therapy.

In Vitro Development of Resistance to Human Immunodeficiency Virus Protease Inhibitor GW640385

R. Elston, P. Yates, L. Boone, 2006, Antimicrobial Agents and Chemotherapy.